An integrative pharmacokinetic-cardiovascular physiology modelling approach based on in vivo dog studies including five reference compounds
{{output}}
Cardiovascular (CV) effects represent a major safety issue during drug development. Typically, this risk is mitigated by preclinical in vivo CV studies, based on which measured CV readouts are analyzed independently. Here, we apply a regression approach to sim... ...
